PPARA and endothelial dysfunction: Some preclinical studies suggest that treatment with PPARα agonists benefits stroke outcome by eliciting anti-inflammatory effects in the CNS and the periphery [11,12,14,15,16], while other studies report that PPARα activation reduces endothelial dysfunction and blood–brain barrier (BBB) breakdown after stroke [17,18].